Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Symbravo medication information ema europa eu?Allergan's patent for latisse expired?When will generic fiasap insulin be available?Can berries enhance lipitor's cholesterol lowering effects?Can grapefruit consumption affect lipitor's efficacy?
See the DrugPatentWatch profile for cosentyx
Cosentyx (secukinumab) suppresses IL-17 and weakens immune responses, reducing vaccine effectiveness—especially for live vaccines—and raising infection risk post-vaccination.[1]
Avoid live vaccines (e.g., MMR, varicella, oral polio, yellow fever) during Cosentyx treatment and for 4–6 weeks after stopping. Live vaccines can cause infection in immunocompromised patients.[1][2]
No required spacing for inactivated vaccines (e.g., flu shot, Tdap, pneumococcal) or mRNA COVID-19 vaccines. Administer them while on Cosentyx, though antibody responses may be lower. Boosters might be needed.[1][3]
Some patients report mild injection-site reactions when vaccinating on the same day as Cosentyx, but no widespread issues. Studies show COVID-19 vaccines remain safe and somewhat effective on biologics like Cosentyx.[3] [1]: Cosentyx Prescribing Information (Novartis) [2]: CDC Guidelines on Immunosuppressants and Vaccines [3]: Study on Secukinumab and Vaccine Response (PubMed)
Other Questions About Cosentyx :